Rare Cancer News & Clinical Trials » Trial

Erector Spinae Plane Block Versus Intercostal for VATS

Posted: April 4th, 2019, 2:00pm GMT

Conditions: Lung Cancer; Lung Diseases
Interventions: Procedure: ESP block; Procedure: Sham ESP block
Sponsor: McGill University Health Center
Not yet recruiting

Permalink for 'The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)'

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Posted: April 1st, 2019, 2:00pm GMT

Conditions: Cancer, All Types; Cancer of Liver; Cancer of Stomach; Cancer of Head and Neck; Cancer of Rectum; Cancer of Kidney; Cancer of Esophagus; Cancer of Colon; Cancer Skin; Cancer of Cervix; Cancer, Metastatic; Cancer of Larynx; Cancer of Neck; Cancer of Lung; Cancer of Brain and Nervous System; Cancer of Vulva, Disseminated; Cancer of Pancreas; Sarcoma; GIST; Small-cell Lung Cancer; Adenocarcinoma Lung; Cancer of Prostate; Cancer, Advanced; Adrenal Cancer; Testicular Cancer; Uterine Cancer; Bronchoalveolar Cell Lung Cancer; Cancer Unknown Primary; Glioblastoma Multiforme; Oligodendroglioma; Breast Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Cholangiocarcinoma; Squamous Cell Carcinoma; Transitional Cell Carcinoma; Cancer, Other; Cancer, Anal; Melanoma; Cancer, Bile Duct; Cancer, Bladder; Cancer Cords Vocal; Cancers Cell Neuroendocrine; Cancer Differentiated Poorly; Cancer, Anaplastic Thyroid
Intervention:
Sponsors: SpeciCare; Dana-Farber Cancer Institute; Kalispell Regional Medical Center; Georgia Institute of Technology; Ontario Institute for Cancer Research; SEngine Precision Medicine; Helomics
Recruiting

Comparing the Efficacy of Local Anesthetics in Mohs Surgery

Posted: March 12th, 2019, 2:00pm GMT

Conditions: Lidocaine; Bupivacaine; Mohs Surgery; Anesthetic
Interventions: Drug: Lidocaine; Drug: Bupivacaine; Drug: Lidocaine and Bupivacaine
Sponsors: Ottawa Hospital Research Institute; Richard J. MacKay Endowment Fund; Benefactor Life Members’ Research Grant; The Ottawa Hospital Division of Dermatology
Not yet recruiting

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Posted: March 5th, 2019, 3:00pm GMT

Condition: Metastatic Tumors
Interventions: Radiation: palliative radiotherapy; Radiation: Stereotactic ablative radiotherapy
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Beatson Institute for Cancer Research, Scotland; The Alfred; Beacon Hospital, Ireland
Not yet recruiting

Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery

Posted: February 12th, 2019, 3:00pm GMT

Condition: Pancreatic Neoplasms
Interventions: Drug: Propranolol and etodolac; Other: Placebo
Sponsors: Assaf-Harofeh Medical Center; Sheba Medical Center
Not yet recruiting

Analgesia of Erector Spinae Plane Block Versus Quadratus Lumborum Block

Posted: January 14th, 2019, 3:00pm GMT

Condition: Colorectal Cancer
Interventions: Other: Erector spinae plane block; Other: Quadratus lumborum block; Drug: Propofol; Drug: Fentanyl NCS; Drug: Atracurium Injectable Product; Other: Endotracheal intubation; Drug: Anesthesia Maintenance; Drug: Muscle Relaxation
Sponsor: Mansoura University
Not yet recruiting

A Study of ASP1951 in Subjects With Advanced Solid Tumors

Posted: January 10th, 2019, 3:00pm GMT

Condition: Advanced Solid Tumors
Intervention: Drug: ASP1951
Sponsor: Astellas Pharma Global Development, Inc.
Recruiting

Conventional ADT w/ or w/Out Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Posted: December 18th, 2018, 3:00pm GMT

Condition: Prostate Cancer
Interventions: Drug: Prednisone; Drug: Apalutamide; Drug: Abiraterone Acetate; Drug: LHRH Agonist or Antagonist
Sponsors: Dana-Farber Cancer Institute; Janssen Scientific Affairs, LLC
Not yet recruiting

Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome

Posted: December 3rd, 2018, 3:00pm GMT

Condition: Breast Neoplasm
Intervention:
Sponsors: St. Olavs Hospital; Norwegian University of Science and Technology
Not yet recruiting

Functional MRI Study Reconstructed Breasts

Posted: October 11th, 2018, 2:00pm GMT

Condition: Breast Cancer
Intervention: Device: MRI scan
Sponsor: Maastricht University Medical Center
Recruiting

The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.

Posted: September 18th, 2018, 2:00pm GMT

Condition: Prostate Cancer
Intervention: Behavioral: High Intensity Interval Training bout
Sponsor: Rigshospitalet, Denmark
Recruiting

Cabozantinib in Advanced Adrenocortical Carcinoma

Posted: August 2nd, 2018, 2:00pm GMT

Condition: Adrenocortical Carcinoma
Intervention: Drug: Cabozantinib-s-malate
Sponsor: Wuerzburg University Hospital
Not yet recruiting

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Posted: December 15th, 2017, 3:00pm GMT

Conditions: Adrenal Gland Neoplasm; Hypertension; Bone Diseases, Metabolic; Cardiovascular Disease; Hyperinsulinemia
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Posted: July 2nd, 2017, 2:00pm GMT

Conditions: Pheochromocytoma; Paraganglioma; Neuroendocrine Tumors; Neuroendocrine Neoplasms
Interventions: Drug: Lu-177-DOTATATE; Drug: Ga-68-DOTATATE; Drug: F-18-FDG; Drug: Amino Acid solution
Sponsor: National Cancer Institute (NCI)
Recruiting

Permalink for 'A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer'

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Posted: May 24th, 2017, 2:00pm GMT

Conditions: Paraganglioma; Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Renal Neoplasms; Pheochromocytoma
Intervention: Drug: SGI-110 (guadecitabine)
Sponsor: National Cancer Institute (NCI)
Recruiting

Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Posted: May 15th, 2017, 2:00pm GMT

Condition: Prostate Carcinoma
Interventions: Other: Laboratory Biomarker Analysis; Drug: Propranolol Hydrochloride; Other: Questionnaire Administration; Other: Survey Administration
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting

Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer

Posted: April 21st, 2017, 2:00pm GMT

Conditions: Hormone-Resistant Prostate Cancer; Recurrent Prostate Carcinoma; Stage I Prostate Cancer; Stage II Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer
Interventions: Procedure: Biospecimen Collection; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Posted: February 16th, 2017, 3:00pm GMT

Conditions: Metastatic Malignant Neoplasm in Lymph Node; Metastatic Malignant Neoplasm in the Adrenal Gland; Metastatic Malignant Neoplasm in the Lung; Metastatic Malignant Neoplasm in the Pancreas; Metastatic Malignant Neoplasm in the Skin; Metastatic Malignant Neoplasm in the Soft Tissues; Metastatic Renal Cell Carcinoma; Oligometastasis; Sarcomatoid Renal Cell Carcinoma; Stage II Renal Cell Cancer AJCC v7; Stage III Renal Cell Cancer AJCC v7; Unclassified Renal Cell Carcinoma
Interventions: Procedure: Conventional Surgery; Biological: Nivolumab; Other: Patient Observation; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: National Cancer Institute (NCI); Canadian Cancer Trials Group
Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Posted: January 9th, 2017, 3:00pm GMT

Condition: Previously Untreated Acute Myeloid Leukemia
Interventions: Biological: Samalizumab (BAML-16-001-S1); Biological: BI 836858 (BAML-16-001-S2); Other: Laboratory Biomarker Analysis; Drug: Daunorubicin (BAML-16-001-S1); Drug: Cytarabine (BAML-16-001-S1); Drug: Azacitidine (BAML-16-001-S2); Drug: AG-221 (BAML-16-001-S3); Drug: Azacitidine (BAML-16-001-S3); Drug: Entospletinib (BAML-16-001-S4); Drug: Azacitidine (BAML-16-001-S4); Drug: Entospletinib (BAML-16-001-S5); Drug: Decitabine (BAML-16-001-S5); Drug: Entospletinib (BAML-16-001-S6); Drug: Azacitidine (BAML-16-001-S6); Drug: Daunorubicin (BAML-16-001-S6); Drug: Cytarabine (BAML-16-001-S6); Drug: Pevonedistat (BAML-16-001-S9); Drug: Azacitidine (BAML-16-001-S9); Drug: AG-120 (BAML-16-001-S16); Drug: Azacitidine (BAML-16-001-S16); Drug: Gilteritinib (BAML-16-001-S8); Drug: Decitabine (BAML-16-001-S8)
Sponsor: Beat AML, LLC
Recruiting

Permalink for 'Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery'

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

Posted: January 2nd, 2017, 3:00pm GMT

Conditions: Malignant Adrenal Gland Pheochromocytoma; Malignant Paraganglioma; Metastatic Adrenal Gland Pheochromocytoma
Interventions: Other: Laboratory Biomarker Analysis; Drug: Lenvatinib; Other: Quality-of-Life Assessment
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting

Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions

Posted: December 6th, 2016, 3:00pm GMT

Conditions: Solitary Pulmonary Nodule; Multiple Pulmonary Nodules
Intervention: Procedure: transbronchial biopsy
Sponsors: University of Pennsylvania; Andrew Haas; Anil Vachani; Anthony Lanfranco; Kevin Ma; Jeffrey Thompson; Edmund Moon
Recruiting

The MATCH Study: Mindfulness And Tai Chi for Cancer Health

Posted: June 15th, 2016, 2:00pm GMT

Condition: Cancer
Interventions: Behavioral: Mindfulness Based Cancer Recovery (MBCR); Behavioral: Tai Chi/Qigong (TCQ) for Cancer Patients
Sponsors: Linda E. Carlson; University of Calgary; Alberta Health Services; Tom Baker Cancer Centre; Princess Margaret Hospital, Canada
Recruiting

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

Posted: April 15th, 2016, 2:00pm GMT

Condition: Malignant Neoplasms of Male Genital Organs
Interventions: Procedure: Caudal Nerve Block (CNB); Drug: Ropivacaine; Drug: Epinephrine; Drug: Decadron; Drug: Clonidine; Drug: Propofol; Behavioral: Phone Call
Sponsors: M.D. Anderson Cancer Center; Merck Sharp & Dohme Corp.
Recruiting

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Posted: February 3rd, 2016, 3:00pm GMT

Condition: Adrenocortical Carcinoma
Intervention: Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center; Merck Sharp & Dohme Corp.
Recruiting

Exercise Intervention for LGBT Cancer Survivors

Posted: June 2nd, 2015, 2:00pm GMT

Condition: Neoplasms
Intervention: Behavioral: Exercise for Cancer Patients
Sponsor: University of Rochester
Recruiting

The Effect of the Serratus Block on Pain Control After Breast Surgery

Posted: May 25th, 2015, 2:00pm GMT

Condition: Anesthesia
Interventions: Procedure: Serratus Block; Procedure: Placebo Block; Drug: ropivacaine; Drug: epinephrine; Other: sterile saline
Sponsor: Women's College Hospital
Recruiting

USDA Western Human Nutrition Research Center (WHNRC) Cross-Sectional Nutritional Phenotyping Study

Posted: February 20th, 2015, 3:00pm GMT

Conditions: Obesity; Inflammation
Intervention:
Sponsor: USDA, Western Human Nutrition Research Center
Recruiting

Permalink for 'Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas'

Study to Evaluate the Effects of Cabozantinib in Patients With Unresectable Metastatic Pheochromocytomas and Paragangliomas

Posted: November 27th, 2014, 3:00pm GMT

Condition: Neuroendocrine Tumors
Interventions: Drug: Cabozantinib; Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; Exelixis
Recruiting

Phase I/II Study of MEK162 for Children With Ras/Raf Pathway Activated Tumors

Posted: November 7th, 2014, 3:00pm GMT

Conditions: Low-Grade Gliomas; Malignant Neoplasms, Brain; Soft Tissue Neoplasms
Intervention: Drug: MEK162
Sponsors: Children's Hospital Los Angeles; Dana-Farber Cancer Institute
Recruiting

Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma

Posted: June 27th, 2011, 2:00pm GMT

Condition: Cushing Syndrome
Intervention: Procedure: surgery
Sponsors: Samsung Medical Center; Asan Medical Center; Severance Hospital; Konkuk University Medical Center
Recruiting

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Posted: June 8th, 2011, 2:00pm GMT

Condition: Prostate Cancer
Interventions: Radiation: radiation therapy; Radiation: Whole-pelvic radiotherapy (WPRT)
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI); NRG Oncology
Recruiting

Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome

Posted: November 23rd, 2010, 3:00pm GMT

Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
Sponsor: Region Skane
Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Posted: November 2nd, 2009, 3:00pm GMT

Conditions: Endocrine Tumors; Thyroid Neoplasms; Parathyroid Neoplasms; Adrenal Neoplasm; Neuroblastoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Posted: January 8th, 2008, 3:00pm GMT

Condition: Neuroblastoma
Intervention: Other: Tumor and Marrow Markers
Sponsors: Memorial Sloan Kettering Cancer Center; Southern Illinois University; Spanish National Cancer Center; St. Jude Children's Research Hospital; Washington University School of Medicine; University of Texas; Weill Medical College of Cornell University
Recruiting

Study of Adrenal Gland Tumors

Posted: June 29th, 2000, 2:00pm GMT

Condition: Adrenal Gland Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Rare Cancer News & Clinical Trials » Trial - Adrenal Cancer

Feeds

Trial - Adrenal Cancer (35 unread)